ACORDA THERAPEUTICS (ACOR) AND BIOGEN (BIIB) RUMOR MONGERS OUT IN FORCE
Acorda Therapeutics (ACOR) rumor spreaders are out in force. They are misleading the uninformed investors about a statement Biogen (BIIB) just made at a conference. We have taken partial profits on Acorda at $30.20. Our highest short tranche in Acorda is from $33.48. The rumor related to Biogen buying Acorda is proven false. However, we are exiting Acorda with profit at $31.16 in the interest of defensive trading. With this cover, we will exit the position completely. If there are new actionable signals on Acorda, we will provide those in real-time to subscribers. 30 day free trial